Á¦42Â÷ 2023³âµµ ´ëÇѽŰæ°úÇÐȸ Ãß°èÇмú´ëȸ DAY 2 : 2023-11-11
±³À°ÀÏÀÚ : 2023-11-11
±³À°Àå¼Ò : ¼¿ï ½ºÀ§½º±×·£µå È£ÅÚ ÄÁº¥¼Ç¼¾ÅÍ 3F Emerald Hall A,B , 4F Convention Hall A,B,C
±³À°ÁÖÁ¦ : Á¦42Â÷ 2023³âµµ ´ëÇѽŰæ°úÇÐȸ Ãß°èÇмú´ëȸ DAY 2
ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
´ã´çÀÚ : ´ëÇѽŰæ°úÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-737-6530
À̸ÞÀÏ : kna@neuro.or.kr
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 22 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 160,000¿ø
ºñ°í »çÀüµî·Ïºñ: Á¤È¸¿ø- Àü¹®ÀÇ 10¸¸¿ø, ÀüÀÓÀÇ,±ºº¹¹«- 6¸¸¿ø, ÁØȸ¿ø- Àü°øÀÇ 6¸¸¿ø, ºñȸ¿ø- Ÿ°ú 16¸¸¿ø, ÇDZ³À°ÀÚ(¿¬±¸¿ø µî) 8¸¸¿ø, ÀÇ°ú´ëÇРȤÀº ÀÇÀü¿ø»ý 1¸¸¿ø ÇöÀåµî·Ïºñ: Á¤È¸¿ø- Àü¹®ÀÇ 12¸¸¿ø, ÀüÀÓÀÇ,±ºº¹¹«- 8¸¸¿ø, ÁØȸ¿ø- Àü°øÀÇ 8¸¸¿ø, ºñȸ¿ø- Ÿ°ú 16¸¸¿ø, ÇDZ³À°ÀÚ 8¸¸¿ø, ÀÇ°ú´ëÇРȤÀº ÀÇÀü¿ø»ý 2¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 08:40~09:00 Clinical- anatomical syndromes of posterior circulation stroke: An overview ±èÁ¾¼º(°¸ª¾Æ»êº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 09:00~09:20 Summary of clinical trial results of EVT in acute basilar occlusion and suggested indication À̹οì(ÇѸ²´ë¼º½Éº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 09:20~09:40 Improving outcome of EVT in acute basilar occlusion– specific considerations ±èÁß±¸(Á¦Áִ뺴¿ø)
Åä·Ð 11¿ù 11ÀÏ Convention Hall A (4F) 09:40~09:50 Q&A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 08:40~09:00 Myasthenia gravis: clinical features and diagnosis ¼®Èï¿(°è¸í´ëµ¿»êÀÇ·á¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 09:00~09:20 Pathogenesis of myasthenia gravis Á¤ÇýÀ±(¿¬¼¼´ë¿ëÀμ¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 09:20~09:40 New targeted therapies in myasthenia gravis ±èÇöÁø(¼¿ï¾Æ»êº´¿ø)
Åä·Ð 11¿ù 11ÀÏ Convention Hall B (4F) 09:40~09:50 Q&A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 08:40~09:00 Overview of vestibular system ÀÌÅ°æ(¼øõÇâ´ëºÎõº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 09:00~09:20 Cognition and vestibular system ¿À¼±¿µ(ÀüºÏ´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 09:20~09:40 Autonomic nervous system and vestibular system À̼±¿í(°í·Á´ë¾È¾Ïº´¿ø)
Åä·Ð 11¿ù 11ÀÏ Convention Hall C (4F) 09:40~09:50 Q&A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 10:00~10:25 Case-Based Learning: ÀÌ»ó¿îµ¿ ½ÅÁ¤È¯(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 10:25~10:50 Case-Based Learning:½Å°æÀ̾Ȱú ÀÌÀͼº(¼øõÇâ´ëºÎõº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 10:50~11:15 Case-Based Learning:½Å°æÁßȯÀÚÀÇÇÐ ¾È¼ºÈ£(¾ç»êºÎ»ê´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 11:15~11:40 Case-Based Learning:³úÀüÁõ ±è°æ¹Î(¿¬¼¼´ë¼¼ºê¶õ½ºº´¿ø)
Åä·Ð 11¿ù 11ÀÏ Convention Hall A (4F) 11:40~12:00 Q&A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 10:00~10:15 Updates on Medications for Neurologist: Stroke Á¤¼ö(ÇѾç´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 10:15~10:30 Updates on Medications for Neurologist:Neuromuscular/motor neuron disorders ¿À¼ºÀÏ(°æÈñ´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 10:30~10:45 Updates on Medications for Neurologist:Epilepsy/Sleep À±ÁöÀº(¼øõÇâ´ëºÎõº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 10:45~11:00 Updates on Medications for Neurologist:Multiple sclerosis/other CNS demyelinating diseases ±èÁöÀº(ÀÌÈÀǴ뼿ﺴ¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 11:00~11:15 Updates on Medications for Neurologist:Dementia ±è¿¹½Å(°¿ø´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 11:15~11:30 Updates on Medications for Neurologist:Movement À̸íÁØ(°¿ø´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 11:30~11:45 Updates on Medications for Neurologist:Headache ¹è´ë¿õ(°¡Å縯´ë¼ººó¼¾Æ®º´¿ø)
Åä·Ð 11¿ù 11ÀÏ Convention Hall B (4F) 11:45~12:00 Q&A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 10:00~10:30 Neurobiological mechanism of neuropathic pain ¿À¼®¹è(¼¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø »ý¸®Çб³½Ç)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 10:30~11:00 Psychosocial impact of neuropathic pain ÃÖ±³¹Î(¼øõÇâ´ëõ¾Èº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 11:00~11:30 Pharmacological management of neuropathic pain ¼¹üõ(°ºÏ»ï¼ºº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 11:30~12:00 Neuromodulation for neuropathic pain À¯¿ëÀç(¼¿ï´ëº´¿ø ¸¶ÃëÅëÁõÀÇÇаú)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 10:00~10:30 Why treat insomnia and what is CBT-I? Donn Posner(Stanford University)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 10:30~11:00 CBT-I: Beyond what we know - "known unknowns" Michael Perlis(University of Pennsylvania)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 11:00~11:30 Insomnia medication : Safety, Efficacy, and Placebo effect Michael Perlis(University of Pennsylvania)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 11:30~11:50 Adaptation of CBT-I in Older Adults ±èÇö(Columbia University)
Åä·Ð 11¿ù 11ÀÏ Emerald Hall A (3F) 11:50~12:00 Q&A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 14:10~14:30 Neuropalliative care_a practical guide for the neurologist À¯¼ö¿¬(°è¸í´ëµ¿»êÀÇ·á¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 14:30~15:00 ½Å°æ°ú ȯÀÚ¸¦ À§ÇÑ ÀçÅÃÀÇ·á¿Í ¿ÏÈÀÇ·á À̼±¿µ(¼¿ï´ëº´¿ø ÀçÅÃÀÇ·áŬ¸®´Ð)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 15:00~15:20 Neuropalliative care for acute neurologic illness ±è¿µ¼ö(°æ»ó´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 15:20~15:40 Neuropalliative care for progressive neurologic disease ¼Áö¿ø(±¹¸³Áß¾ÓÀÇ·á¿ø)
Åä·Ð 11¿ù 11ÀÏ Convention Hall B (4F) 15:40~15:50 Q&A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 14:10~14:40 ÀÎÁöÀå¾Ö ȯÀÚ¸¦ À§ÇÑ ÀÎÁöÁßÀçÄ¡·áÀÇ ½ÇÁ¦¿Í ¹Ì·¡ ¿Õ¹ÎÁ¤(·Î¾Æ½Å°æ°úÀÇ¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 14:40~15:10 TCD¸¦ È°¿ëÇÑ µÎÅëÀÇ Áø´Ü°ú Ä¡·á Á¤Áø»ó(Á¤Áø»ó½Å°æ°úÀÇ¿ø)
Åä·Ð 11¿ù 11ÀÏ Convention Hall C (4F) 15:10~15:20 Q&A ()
ÈÞ½Ä 11¿ù 11ÀÏ Convention Hall C (4F) 15:20~15:30 Break ()
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 15:30~16:00 ÃÊÀ½Æĸ¦ È°¿ëÇÑ ÅëÁõ Ä¡·á Çѹü±â(¿¬¼¼½Å°æ°úÀÇ¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 16:00~16:30 EMG/NCS¸¦ ÀÌ¿ëÇÑ ¼ö¼ú Àü ½Å°æ°ú ÇùÁø Áø·áÀÇ ¿ªÇÒ ±è±¤±¹(±è±¤±¹½Å°æ°úÀÇ¿ø)
Åä·Ð 11¿ù 11ÀÏ Convention Hall C (4F) 16:30~16:40 Q&A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 13:00~13:25 ¼ö¸é´Ù¿ø°Ë»ç ÀûÀÀÁõ ¹× Áغñ»çÇ× ¹ÚÀ±°æ(ÇϳªÀ̺ñÀÎÈÄ°úº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 13:25~13:55 Sleep staging and arousals in adults ½ÅÇý¸²(´Ü±¹´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 13:55~14:25 Scoring rules for respiratory events ±èµ¿¿±(ÀÌÈÀǴ뼿ﺴ¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 14:25~14:50 Scoring rules for movement events/ Parasomnia Ȳ¼ºÀº(ÀÌÈÀÇ´ë¸ñµ¿º´¿ø)
Åä·Ð 11¿ù 11ÀÏ Emerald Hall A (3F) 14:50~15:00 Q & A ()
ÈÞ½Ä 11¿ù 11ÀÏ Emerald Hall A (3F) 15:00~15:10 Break ()
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 15:10~15:40 CPAP titration ¹× interpretation ¾çÅ¿ø(â¿ø°æ»ó±¹¸³´ëº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 15:40~16:10 MSLT °Ë»ç ¹æ¹ý ÀÌÇØ¿Í Æǵ¶ ÁÖº´¾ï(¼øõÇâ´ëÇб³º´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 16:10~16:35 ¼ö¸é´Ù¿ø°Ë»çÁö ÀÛ¼º ¹× Çؼ® ÇѼöÇö(Á߾Ӵ뺴¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 16:35~17:00 ¼ö¸é´Ù¿ø°Ë»ç Áß ¹ß»ýÇÏ´Â ÀÀ±Þ»óȲ ÀÌ¿ìÁø(ºÐ´ç¼¿ï´ëº´¿ø)
Åä·Ð 11¿ù 11ÀÏ Emerald Hall A (3F) 17:00~17:10 Q & A ()
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall B (3F) 14:30~15:20 ÀÇ·áºÐÀï»ç·Ê ÀÌ¿µÈ£(¹ý¹«¹ýÀÎ ÀǼº) Çʼö
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall B (3F) 15:20~15:50 ¸¶¾à·ù ¾ÈÀü»ç¿ë ±âÁØ ¹Î¾ç±â(ÇѸ²´ë°³²¼º½Éº´¿ø) Çʼö
±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall B (3F) 15:50~16:30 ¸¶¾à·ùÅëÇÕ°ü¸®½Ã½ºÅÛÀ» ÅëÇÑ ¸¶¾à·ù ¾ÈÀü°ü¸® ¹ÚÁÖ¿¬(Çѱ¹ÀǾàÇ°¾ÈÀü°ü¸®¿ø ¸¶¾à·ùÁ¦µµÁö¿øÆÀ) Çʼö
±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (3F) 16:30~17:30 Ä¡¸ÅƯº°µî±Þ ±³À° ±èÈñÁø(ÇѾç´ëº´¿ø)